[1]韩永康,杜毓锋,钱 力,等.N6-甲基腺苷修饰在呼吸系统疾病中的研究进展[J].陕西医学杂志,2024,(1):136-139,144.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.030]
　HAN Yongkang,DU Yufeng,QIAN Li,et al.Progress in studying RNA m6A modification in respiratory diseases[J].,2024,(1):136-139,144.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.030]
点击复制

N6-甲基腺苷修饰在呼吸系统疾病中的研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
136-139,144
栏目:
综 述
出版日期:
2024-01-31

文章信息/Info

Title:
Progress in studying RNA m6A modification in respiratory diseases
作者:
韩永康1; 杜毓锋2; 钱 力2; 李 丹2; 孙梓越1; 刘学军2
(1.山西医科大学,山西 太原 030012; 2.山西医科大学第一医院老年病科,山西 太原 030001)
Author(s):
HAN Yongkang; DU Yufeng; QIAN Li; LI Dan; SUN Ziyue; LIU Xuejun
(Shanxi Medical University,Taiyuan 030012,China)
关键词:
肺部疾病;  RNA甲基化;  N6-甲基腺苷修饰;  甲基化转移酶;  去甲基化酶;  甲基化阅读蛋白
Keywords:
Pulmonary diseases;  RNA methylation;  N6-Methyladenosine modification;  Methylated transferase;  Demethylated enzyme;  Methylated reading protein
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7377.2024.01.030
文献标志码:
A
摘要:
慢性呼吸系统疾病已成为影响我国居民健康的重要因素,给患者、社会带来沉重的经济负担。表观遗传因素在呼吸系统疾病的发生发展中有重要作用,RNA甲基化是重要表观遗传修饰方式之一,其中6-甲基腺嘌呤(m6A)作为一种转录后修饰方式在真核生物中广泛存在。关注 m6A修饰在肺部疾病中的功能,对深入理解m6A表观遗传学调控规律,阐明肺部疾病的发病机制,提供药物治疗靶点,指导临床诊治具有重要意义。将对RNA m6A修饰在呼吸系统疾病中的研究进展作一综述。
Abstract:
Chronic Respiratory disease have become an important part of the health of Chinese residents,and have a heavy economic burden on patients' families and even the whole society.Epigenetic factors play an important role in the occurrence and development of respiratory diseases,and RNA methylation is one of the important epigenetic modification methods,among which 6-methyladenine(N6-methyladenosine,m6A)is widely present in eukaryotes as a post-transcriptional modification mode.Focusing on the function of m6A modification in lung diseases is of great significance for in-depth understanding of the epigenetic regulation of m6A,elucidating the pathogenesis of lung diseases,providing drug treatment targets,and guiding clinical diagnosis and treatment.This article will review the latest developments in RNA m6A modification in respiratory diseases.

参考文献/References:

[1] ZHOU M,WANG H,ZENG X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:A systematic analysis for the global burden of disease study 2017[J].Lancet,2019,394(10204):1145-1158.
[2] ZHAO Y,SHI Y,SHEN H,et al.m(6)A-binding proteins:The emerging crucial performers in epigenetics[J].J Hematol Oncol,2020,13(1):35.
[3] ZHANG Z,CHEN L Q,ZHAO Y L,et al.Single-base mapping of m(6)A by an antibody-independent method[J].Sci Adv,2019,5(7):eaax250.
[4] GUAN Q,LIN H,MIAO L,et al.Functions,mechanisms,and therapeutic implications of METTL14 in human cancer[J].J Hematol Oncol,2022,15(1):13.
[5] ZHANG X,BLUMENTHAL R M,CHENG X.A Role for N6-Methyladenine in DNA Damage Repair[J].Trends Biochem Sci,2021,46(3):175-183.
[6] SHI H,WEI J,HE C.Where,when,and how:Context-dependent functions of rna methylation writers,readers,and erasers[J].Mol Cell,2019,74(4):640-650.
[7] QU J,YAN H,HOU Y,et al.RNA demethylase ALKBH5 in cancer:From mechanisms to therapeutic potential[J].J Hematol Oncol,2022,15(1):8.
[8] DENG L J,DENG W Q,FAN S R,et al.m6A modification:Recent advances,anticancer targeted drug discovery and beyond[J].Mol Cancer,2022,21(1):52.
[9] XU L,ZHOU L,YAN C,et al.Emerging role of N6-methyladenosine RNA methylation in lung diseases[J].Exp Biol Med(Maywood),2022,247(20):1862-1872.
[10] 黄振峰,于会勇,王成祥.清燥救肺汤联合吡非尼酮治疗特发性肺纤维化疗效及对患者支气管肺泡灌洗液胰岛素样生长因子的影响[J].陕西中医,2023,44(8):1037-1041.
[11] HUANG G,HUANG S,CUI H.Effect of m6A regulators on diagnosis,subtype classification,prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis[J].Front Pharmacol,2022,13:993567.
[12] MOSS B J,RYTER S W,ROSAS I O.Pathogenic mechanisms underlying idiopathic pulmonary fibrosis[J].Annu Rev Pathol,2022,17:515-546.
[13] ZHANG J X,HUANG P J,WANG D P,et al.m(6)A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation[J].Mol Ther,2021,29(12):3436-3448.
[14] DENG M S,CHEN K J,ZHANG D D,et al.m6A RNA methylation regulators contribute to predict and as a therapy target of pulmonary fibrosis[J].Evid Based Complement Alternat Med,2022,242:5065.
[15] LI Z,LI N,GUO C,et al.The global DNA and RNA methylation and their reversal in lung under different concentration exposure of ambient air particulate matter in mice[J].Ecotoxicol Environ Saf,2019,172:396-402.
[16] CHU S,LI X,SUN N,et al.The combination of ultrafine carbon black and lead provokes cytotoxicity and apoptosis in mice lung fibroblasts through oxidative stress-activated mitochondrial pathways[J].Sci Total Environ,2021,799:149420.
[17] HAN B,CHU C,SU X,et al.N(6)-methyladenosine-dependent primary microRNA-126 processing activated PI3K-AKT-mTOR pathway drove the development of pulmonary fibrosis induced by nanoscale carbon black particles in rats[J].Nanotoxicology,2020,14(1):1-20.
[18] 张亚玲.ALKBH5蛋白调节ECM沉积在PM2.5暴露致小鼠肺纤维化的作用机制研究[D].石家庄:河北医科大学,2022.
[19] WANG S,LUO W,HUANG J,et al.The combined effects of circular RNA methylation promote pulmonary fibrosis[J].Am J Respir Cell Mol Biol,2022,66(5):510-523.
[20] ZHANG Y,GU P,XIE Y,et al.Insights into the mechanism underlying crystalline silica-induced pulmonary fibrosis via transcriptome-wide m(6)A methylation profile[J].Ecotoxicol Environ Saf,2022,247:114215.
[21] SUN W,LI Y,MA D,et al.ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1[J].Cell Mol Biol Lett,2022,27(1):26.
[22] WANG N,CONG S,FAN J,et al.Geographical disparity and associated factors of copd prevalence in china:A spatial analysis of national cross-sectional study[J].Int J Chron Obstruct Pulmon Dis,2020,15:367-377.
[23] XIA H,WU Y,ZHAO J,et al.The aberrant cross-talk of epithelium-macrophages via METTL3-regulated extracellular vesicle miR-93 in smoking-induced emphysema[J].Cell Biol Toxicol,2022,38(1):167-183.
[24] 周旭东,吴吉星,夏杰.慢性阻塞性肺疾病患者急性加重影响因素及血清分泌型卷曲相关蛋白1和Clara细胞分泌蛋白对其预测价值[J].陕西医学杂志,2023,52(9):1168-1171.
[25] GUO X,LIN Y,LIN Y,et al.PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification[J].Environ Pollut,2022,303:119115.
[26] O'BEIRNE S L,KIKKERS S A,OROMENDIA C,et al.Alveolar macrophage immunometabolism and lung function impairment in smoking and chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2020,201(6):735-739.
[27] 陈丽娜,薛岑,杜丽娟,等.COPD患者m6A甲基化酶水平观察及FTO对PM2.5刺激后MH-S细胞极化和NF-κB信号活化的影响[J].实用药物与临床,2021,24(7):577-585.
[28] HUANG X,LV D,YANG X,et al.m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease[J].J Cell Mol Med,2020,24(21):12706-12715.
[29] TENG F,TANG W,WUNIQIEMU T,et al.N(6)-methyladenosine methylomic landscape of lung tissues in murine acute allergic asthma[J].Front Immunol,2021,12:740571.
[30] DAI B,SUN F,CAI X,et al.Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of childhood asthma using the gene expression omnibus database[J].Front Genet,2021,12:634162.
[31] FAN L,WU J,WANG H,et al.METTL3-mediated N6-methyladenosine methylation modifies foxp3 mrna levels and affects the treg cells proportion in peripheral blood of patients with asthma[J].Ann Clin Lab Sci,2022,52(6):884-894.
[32] KIM H,LEE Y S,KIM S M,et al.RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis[J].Dev Cell,2021,56(8):1118-1130.
[33] SUN D,YANG H,FAN L,et al.m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma[J].J Cell Mol Med,2021,25(21):10236-10247.
[34] SUN D,CAI X,SHEN F,et al.Transcriptome-wide m6A methylome and m6A-modified gene analysis in asthma[J].Front Cell Dev Biol,2022,10:799459.
[35] LIN Q,NI H,ZHENG Z,et al.Cross-talk of four types of RNA modification writers defines the immune microenvironment in severe asthma[J].Ann N Y Acad Sci,2022,1514(1):93-103.
[36] MO B W,LI X M,LI S M,et al.m6A echoes with DNA methylation:Coordinated DNA methylation and gene expression data analysis identified critical m6A genes associated with asthma[J].Gene,2022,828:146457.
[37] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[38] SUPHAKHONG K,TERASHIMA M,WANNA-UDOM S,et al.m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells[J].J Biol Chem,2022,298(11):102554.
[39] MA L,XUE X,ZHANG X,et al.The essential roles of m(6)A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma[J].J Exp Clin Cancer Res,2022,41(1):36.
[40] ZHU Z,QIAN Q,ZHAO X,et al.N(6)-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability[J].Gene,2020,731:144348.
[41] LIU X,MA C,LIU H,et al.M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer[J].J Cancer Res Clin Oncol,2022,148(10):2803-2814.
[42] ZHANG B,CHEN Z,TAO B,et al.M6A target microRNAs in serum for cancer detection[J].Mol Cancer,2021,20(1):170.

备注/Memo

备注/Memo:
基金项目:山西省自然科学基金资助面上项目(20210302123248); 山西省青年科学研究项目(202203021222373)
更新日期/Last Update: 2024-01-05